Elyxium Wealth’s BeOne Medicines Ltd ONC Stock Holding History

Elyxium Wealth’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	-$1.82K	–	1339
2025 Q4	$1.82K	Buy	+6	New	+$1.96K	﹤0.01%	1127

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Elyxium Wealth's ONC Position: Q1 2026 in Review

Elyxium Wealth sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 6 shares — an estimated $1.82K sold.

Elyxium Wealth first reported a position in ONC in Q4 2025 and held it in 1 quarter. The position peaked at $1.82K in Q4 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Elyxium Wealth reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
Elyxium Wealth sold 6 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.82K.
Elyxium Wealth first reported a position in BeOne Medicines Ltd in Q4 2025 and held it in 1 quarter.
Elyxium Wealth's BeOne Medicines Ltd position peaked at $1.82K in Q4 2025.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.